Horama is developing gene therapies for rare retinal diseases. Its lead program is the most advanced gene therapy for the treatment PDE6β-related retinitis pigmentosa.

biopharmaceuticals
Private
Visit Website

http://www.horama.fr/

Additional Portfolio Companies
Abcuro
Abcuro
Adicet Bio
Adicet Bio
AgomAb Therapeutics
AgomAb Therapeutics
Allena Pharmaceuticals
Allena Pharmaceuticals
ArQule
ArQule
Cathworks
Cathworks
cCAM Biotherapeutics
cCAM Biotherapeutics
CheckCap
CheckCap
CytoReason
CytoReason
Dynacure
Dynacure
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals
Enlivex Therapeutics
Enlivex Therapeutics
Eyevensys
Eyevensys
EyeYon
EyeYon
ForSight Vision6 (“V6”)
ForSight Vision6 (“V6”)
Genocea
Genocea
Horama
Horama
IMEL Biotherapeutics
IMEL Biotherapeutics
Immunic Therapeutics
Immunic Therapeutics
Kamari Pharma
Kamari Pharma
Keros Therapeutics
Keros Therapeutics
Kite Pharma
Kite Pharma
Levation Pharma
Levation Pharma
LogicBio Therapeutics
LogicBio Therapeutics
Lutris Pharma
Lutris Pharma
Mereo BioPharma
Mereo BioPharma
Metabomed
Metabomed
NovellusDX
NovellusDX
Ocon Medical
Ocon Medical
Opiant
Opiant
PACT Pharma
PACT Pharma
Pi Therapeutics
Pi Therapeutics
Prevail Therapeutics
Prevail Therapeutics
Precirix (Formerly Camel-IDS)
Precirix (Formerly Camel-IDS)
ProQR
ProQR
Protalix
Protalix
Raziel Therapeutics
Raziel Therapeutics
ReWalk
ReWalk
Saniona
Saniona
SilverBack Therapeutics
SilverBack Therapeutics
Soligenix
Soligenix
Stargazer Pharmaceuticals
Stargazer Pharmaceuticals
VBI Vaccines
VBI Vaccines
Step Pharma
Step Pharma
StimatixGI
StimatixGI
Sweetch
Sweetch
TargEDys
TargEDys
Vascular Graft Solutions
Vascular Graft Solutions
UroGen
UroGen
V-Wave
V-Wave
November 15, 2017